Navigation Links
Medizone International, Inc. (MZEI.PK) Announces it has Established its Own BSL2A Certified Laboratory Located in Innovation Park, Queen's University at Kingston, Ontario, Canada.
Date:7/7/2009

SAN FRANCISCO, July 7 /PRNewswire-FirstCall/ -- "This is a fully equipped bio-safety level 2 laboratory dedicated exclusively to Medizone research," stated Dr. Michael Shannon Director of Medical Affairs for Medizone. "This new laboratory is located in the heart of one of the finest bio-medical communities in the country and will provide a primary research and development platform for the Corporation as it proceeds down what is now a clear path to commercialization with its lead product, AsepticSure(TM). Given the outstanding range of bactericidal kill rates we have achieved to date ( 4.4 log /99.994% to 5 log /99.999%) with the pathogens most often associated with hospital derived infections, it has become clear there are opportunities abounding to expand our scientific horizons through collaborative arrangements in many diverse and exciting new applications. The current pandemic of H1 N1 influenza occurring world-wide reminds us how vulnerable we are to new infectious diseases and why new advanced and innovative technologies that combat such infectious agents are seriously needed. The Medizone AsepticSure(TM) system is just such an innovation in the battle against infections which claim countless lives every day world-wide. The Company now has a platform to continue an expanded laboratory research program even as it prepares for the commencement of hospital beta testing of its hospital sterilization system later this summer."

Medizone International, Inc. is a research and development company engaged in developing its AsepticSure(TM) technology to decontaminate and sterilize hospital surgical suites, emergency rooms, intensive care units, schools and other critical infrastructure. If current trials continue to proceed successfully they will be followed by a hospital mock-up and then hospital beta testing of the production prototype. Initial sales are targeted to commence in the 4 quarter of this year.

This press release contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. The company disclaims any obligation or intention to update any forward-looking statement.

         Investor Relations: 800-953-3350 / web site: www.medizoneint.com
                       E-mail: operations @ medizoneint.com


'/>"/>
SOURCE Medizone International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Medizone International, Inc. Announces Strategic Consulting Relationship With TDV Global, Inc.
2. The Canadian Foundation for Global Health Announces a Research and Development Partnership with Medizone International, Inc.
3. Medizone Announces a Second Round of Trials Have Begun.
4. Medizone Announces That Its AsepticSure(TM) Development Program is Reaching Objectives on Two Fronts
5. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
6. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
7. Natural Alternatives International, Inc. Announces Late Filing of its Annual Report on Form 10-K, Revenue for Fiscal 2007 and Guidance on First Quarter of Fiscal 2008
8. Cryo-Cell International, Inc. Reports Third Quarter 2007 Results
9. TenderCare International, Inc. Announces Signing of Merger Agreement with the Hain Celestial Group for All Outstanding Shares of TenderCare Stock
10. Chindex International, Inc. Announces Results for the Quarter and Six Months Ended September 30, 2007
11. DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... Santa Rosa, CA (PRWEB) , ... January 24, 2017 , ... ... rates is good news for everyone and particularly good news for prostate cancer patients: ... from the diagnosis. , According to the report the cancer death rate has dropped ...
(Date:1/24/2017)... ... 2017 , ... A yellow fever outbreak in Brazil has infected over 100 ... primarily spread through contact with infected mosquitos. The outbreak has sparked increased concern about ... , According to multiple health organizations, the best way to prevent yellow fever is ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... ... for everyday use to improve the connection with God. “Spiritual Vitamins: A Spiritual ... author. , Published by Christian Faith Publishing, Mathai Yohannan’s new book engages the ...
(Date:1/24/2017)... (PRWEB) , ... January 23, 2017 , ... ... refined coffee house-caliber protein and espresso drink, announced its CLICK® Coffee Protein Drink ... , CLICK® Coffee Protein Drink Mix has become popular among health-conscious consumers who ...
(Date:1/24/2017)... ... January 23, 2017 , ... Texas Home ... acquisitions of two personal care service companies: Padre Home Health in Corpus Christi, ... 1, 2017. , Well regarded in their respective markets, these two agencies align ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... Jan. 24, 2017 Mezzion has filed a ... State court alleging that Dr. Reddy,s committed fraud relating ... and Drug Administration (FDA) cGMP practices, and misrepresenting its ... repeatedly represented to Mezzion that it was compliant with ... Mezzion.  The suit also states that Dr. Reddy,s misconduct ...
(Date:1/24/2017)... , Jan 24, 2017 Research and Markets ... Trends - Sensor, Actuator - Forecast to 2025" report to ... ... around 17.6% over the next decade to reach approximately $76.24 million ... market is witnessing include growing count of labs using optogentic techniques ...
(Date:1/24/2017)... Stock-Callers.com today has issued research reports ... ZTS ), Mallinckrodt PLC (NYSE: MNK ), Akorn ... (NYSE: DPLO ). According to pharmaceutical manufacturer PCI ... for the Generic Drugs industry, including a possible reduction in ... growth, and a speedier FDA approval process that could reduce ...
Breaking Medicine Technology: